BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3512169)

  • 1. Cholinesterase phenotyping: clinical aspects and laboratory applications.
    Evans RT
    Crit Rev Clin Lab Sci; 1986; 23(1):35-64. PubMed ID: 3512169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choice of the most appropriate methods for the investigation of serum cholinesterase status.
    Evans RT
    Z Med Lab Diagn; 1986; 27(5):245-7. PubMed ID: 3776297
    [No Abstract]   [Full Text] [Related]  

  • 3. Is serum cholinesterase activity a predictor of succinyl choline sensitivity? An assessment of four methods.
    Evans RT; Wroe J
    Clin Chem; 1978 Oct; 24(10):1762-6. PubMed ID: 699286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal cholinesterase activity: understanding and interpretation.
    Jokanović M; Maksimović M
    Eur J Clin Chem Clin Biochem; 1997 Jan; 35(1):11-6. PubMed ID: 9156559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme reactivator treatment in organophosphate exposure: clinical relevance of thiocholinesteratic activity of pralidoxime.
    Petroianu GA; Missler A; Zuleger K; Thyes C; Ewald V; Maleck WH
    J Appl Toxicol; 2004; 24(6):429-35. PubMed ID: 15551381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple liquid chromatography linked to tandem mass spectrometry method for measurement of serum cholinesterase activity using succinylcholine as substrate.
    Spencer JD; Rushton D; Allen KR
    Ann Clin Biochem; 2010 May; 47(Pt 3):217-22. PubMed ID: 20392750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assay using succinyldithiocholine as substrate: the method of choice for the measurement of cholinesterase catalytic activity in serum to diagnose succinyldicholine sensitivity.
    Mosca A; Bonora R; Ceriotti F; Franzini C; Lando G; Patrosso MC; Zaninotto M; Panteghini M;
    Clin Chem Lab Med; 2003 Mar; 41(3):317-22. PubMed ID: 12705341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of whole blood cholinesterase in different animal species using specific substrates.
    Tecles F; Cerón JJ
    Res Vet Sci; 2001 Jun; 70(3):233-8. PubMed ID: 11676619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A rare case of silent cholinesterase genetic variant (author's transl)].
    Otte A; Bonilla I; Gil C; Bolinches R; Andreu L; Canós I
    Med Clin (Barc); 1980 Oct; 75(7):309-11. PubMed ID: 7432039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinesterase and succinylcholine.
    Viby-Mogensen J
    Dan Med Bull; 1983 May; 30(3):129-50. PubMed ID: 6345094
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of a commercially available assay system with two reference methods for the determination of plasma cholinesterase variants.
    Whittaker M; Britten JJ; Dawson PJ
    Clin Chem; 1983 Oct; 29(10):1746-51. PubMed ID: 6616819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of stepwise discriminant analysis in the phenotyping of plasma cholinesterase variants.
    Turner JM; Hall RA; Whittaker M; Holder RL; Kricka LJ
    Ann Clin Biochem; 1985 Mar; 22 ( Pt 2)():175-8. PubMed ID: 4004108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged response to succinylcholine: a new variant of plasma cholinesterase that is identified as normal by traditional phenotyping methods.
    Greenberg CP; Primo-Parmo SL; Pantuck EJ; la Du BN
    Anesth Analg; 1995 Aug; 81(2):419-21. PubMed ID: 7618741
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of hemoperfusion and cholinesterase in acute poisoning with organophosphate cholinesterase inhibitors--clinical analysis of 50 patients].
    Mydlík M; Mizla P; Klimcík J; Derzsiová K; Palko S
    Vnitr Lek; 1991; 37(7-8):645-51. PubMed ID: 1755204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pralidoxime as an insignificant reactivator in severe anticholinesterase (organophosphate insecticide) poisoning.
    Ganendran A; Balabaskaran S
    Southeast Asian J Trop Med Public Health; 1976 Dec; 7(4):543-50. PubMed ID: 1030852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibition of cholinesterase activity in human blood plasma by organophosphate insecticides and their metabolites using the delta-pH method].
    Conrad R; Reinhardt R
    Z Gesamte Hyg; 1981 Oct; 27(10):747-50. PubMed ID: 7314702
    [No Abstract]   [Full Text] [Related]  

  • 17. Scope and limitations of propionylthiocholinesterase in the characterisation of cholinesterase variants.
    Price EM; Brown SS
    Clin Biochem; 1975 Dec; 8(6):384-90. PubMed ID: 1204213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of some methods of phenotyping the plasma cholinesterase variants using benzoylcholine as substrate.
    Whittaker M; Britten JJ
    Ann Clin Biochem; 1981 Jan; 18(Pt 1):9-14. PubMed ID: 7259066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two substrates in determination of plasma cholinesterase activity & genetic variability.
    Verma M; Singh S; Nain CK; Ganguly NK; Sharma BK
    Indian J Med Res; 1996 Aug; 104():198-200. PubMed ID: 8840660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinesterase: phenotyping and genotyping.
    Goodall R;
    Ann Clin Biochem; 2004 Mar; 41(Pt 2):98-110. PubMed ID: 15025799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.